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Recent advances in rapidly developing science and technology, especially key discoveries 
in biomedical research have the potential to significantly improve human health quality 
and overcome many health challenges in the world. As a result, many countries, including 
developing countries are increasing the resources dedicated to establishing centers of 
excellence and innovative technology clusters. A world-class research enterprise to conduct 
cutting-edge biomedical research in this century must establish a comprehensive system to 
attract, retain and develop talented researchers from both local and international scientific 
communities. Furthermore, strong mentorship for junior researchers and students must be 
an integral component in these centers. 
The Nazarbayev University of Kazakhstan aims to become a globally recognized teaching 
and research institution so that its students are equipped to compete internationally. 
Academic freedom and institutional independence are legally sanctioned at Nazarbayev 
University, setting it apart from some other universities in Central Asia. In the past two years in 
Kazakhstan funding allocated to science and research has more than doubled in accordance 
with the Ministry of Education and Science reports. Kazakhstan's healthcare spending has 
been experiencing steady growth for past few years as wel l . Upgrading the existing system, 
improving mechanisms for implementation and increasing efficiency and effectiveness of 
professionals working in health services as we l l as increasing quality of medical services 
provided, remain to be the priority area for development. Total financing of science grew 
almost 2.5-fold over the last two years. 
The Ministry of Education and Science (MES) has been focusing on the importance of 
financing of scientific research through financing of educational institutions. More investment 
means more funding is allocated to the development of infrastructure, equipment and 
quality of research. Innovation can be nurtured through adequate investment into not 
only development of infrastructure but also through cultivation of young talent through 
education. More funding is needed to educate promising young scientists and scholars 
leading research centers and institutes. Kazakhstan has seen growth in numbers of young 
scholars and scientists emerging in the region. 
Younger generation is showing increased interest in science majors across the country as 
more and more universities offer scientific majors. The Ministry identified many challenges 
that lay ahead, which include the need for technological modernization of the scientific 
infrastructure, synchronization of science wi th innovative development and encouraging 
cooperation between science and business. In order to streamline this process the Ministry 
has formed a "Science Fund" w i th 21 scientific projects in Kazakhstan that are aimed at 
practical solutions to streamline research. In Kazakhstan, it is of outmost importance 
to prevent losing qualified scientists and researchers to other countries. Kazakhstan's 
government recognizes this issue and encourages cultivating and nourishing home grown 
talent by providing adequate investment into development of first and foremost, educational 
institutions, infrastructure, teaching staff and equipment. Innovation comes wi th invention, 
and invention requires substantial investment, this is the reality that the government has 
taken notice of. 
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Current activities to promote research excellence 
The Nazarbayev University Center for Life Sciences was registered in December, 2010, 
as an independent entity owned by the University and became ful ly operational since June 
2011. The Center's vision is to develop fundamental and obtain new knowledge about the 
nature and behavior of living organisms and to use this knowledge to extend quality of life 
and improve the health of the population in Kazakhstan. The mission of the Center is to be a 
Leader in the transformation of medicine in Kazakhstan by carrying out innovative research 
and translating research results into practice.The Center is focusing on high-level training of 
medical scientists so that they can engage w i th and contribute to the international medical 
research community. 
The Center is embracing the principles of evidence-based medicine and encourages its 
practice. The Center for Life Sciences is a part of an integrated academic health-care system 
that includes six medical centers of the National Medical Holding, a School of Medicine as 
we l l as future Oncology Center. These centers provide care in obstetrics and gynecology, 
neurosurgery, diagnostics, cardiology and cardiac surgery, emergency care, and pediatric 
rehabilitation. As part of this system, the Center for Life Sciences integrates scientific research 
programs wi th clinical practice and education. In 2015, a school of medicine w i l l be added to 
Nazarbayev University, and w i l l be integrated into this system. A challenge facing the Center 
for Life Sciences is to raise the quality of biomedical research in Kazakhstan to international 
standards given budgetary constraints. One way in which the Center is tackling this challenge 
is to develop partnerships wi th leading academic centers internationally and to seek advice 
and input from leaders in this field. Such partnerships were established wi th centers such 
as the University of Pittsburgh, Duke University, Columbia University, NIH, Seoul National 
University, BGI, Oxford University, Cardiff University, University of Brighton, UCL, RIKEN Center 
for Genomic Medicine, Yokohama, Japan, Kyoto University, National Cancer Center of Tokyo. 
Center for Life Science researchers have spent t ime in various training and jo int programs 
at these centers. In 2011 for the first time in Kazakhstan the International Partner Advisory 
Board was convened. 
The International Partner Advisory Board was established as an acting body of Center 
for Life Sciences, which oversees ongoing research activities of the center in the field of 
personalized medicine, genomics and multi-omics research, bioinformatics, global health, 
pharmacogenomics and has been fol lowing the progress and development of number of 
its projects. The mandate of International Partner's Advisory Board is to provide guidance 
and support initiatives proposed by CLS research scientists. Board members were interested 
and engaged in discussions regarding the Center's strategy and research programs. The 
Board provided constructive advice on specific research projects and supported the strategic 
directions of the Center for Life Sciences.CLS scientists have an excellent opportunity to not 
only gain significant expertise and experience, but also to perfect their knowledge through 
collaborative research projects outlines in research initiatives. Advisory Board concurs that 
in order to maintain the quality of research conducted at CLS, it is v i ta l to develop adequate 
infrastructure and provide intensive training to research personnel and abundant investment 
is necessary for further progress. Advisory Board is committed to aiding CLS in achieving its 
research objectives and anticipates that the ultimate outcome of this research w i l l make 
valuable contributions to development of various fields of biomedicine in Kazakhstan and 
beyond. 
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The challenge faced by current biomedical researchers is the difficulty in bringing 
together a collaborative multidisciplinary research team which should include distinguished 
researchers, experienced practitioners and highly skilled industry personnel in order - to 
yield significant research outcomes. Indeed, funders of any research are increasingly seeking, 
more outcome-based indicators of societal and economic impact as they evaluate the value 
of the research. For example, in the United Kingdom, the Higher Education Funding Council 
for England (HEFCE) developed proposals for the Research Excellence Framework (REF) to 
allocate public research funding to higher education institutions, inter alia, on the basis of the 
social and economic impact of their research. Twenty impact indicators from seven categories 
proposed by HEFCE are presented; their strengths and limitations are discussed using insights 
from the relevant biomedical and research policy literature. It was confirmed that that the 
majority of the proposed indicators have some validity, there are significant challenges in 
operationalizing and measuring these indicators reliably, as we l l as in comparing evidence 
of research impact across different cases in a standardized manner. It is suggested that 
the public funding agencies, medical research charities, universities, and the wider medical 
research community work together to develop more robust methodologies for capturing and 
describing impact, including more valid and reliable impact indicators. It is quite common for 
the h-index and the impact factor to be used as the objective measure of research impact. 
At the same time in December 2012 the San Francisco Declaration on Research Assessment 
(DORA) was initiated by the American Society for Cell Biology (ASCB) together wi th a group 
of editors and publishers of scholarly journals, recognizes the need to improve the ways in 
which the outputs of scientific research are evaluated. It was noted that it is a worldwide 
initiative covering al l scholarly disciplines and they encouraged individuals and organizations 
who are concerned about the appropriate assessment of scientific research to sign DORA. 
As Steen (2013) points out, "the San Francisco Declaration on Research Assessment (DORA) 
criticizes Journal Impact Factor (JIF) without offering an alternative". 
Conclusion 
The potential benefits and limitations of bibliometrics in the evaluation of research, as 
we l l as the relationship between metrics and peer review, databases used as sources of 
bibliometric analysis should be assessed wi th caution and in the context of a l l indicators 
of scientific impact. It should be noted as we l l that the fundamental format of scientific 
exchange and publishing, assimilation of scientific information, and teaching pedagogy have 
not changed in a century. In the 21st century our internet-supported culture resulted in 
rapid access to poorly validated information. The pivot of knowledge is s t i l l considered the 
peer-review process, but it is l imited and not measurable. This process does not provide for 
an intensive interaction between the reviewer-author-editor-end user which would be more 
efficient and quantitative. 
To overcome these challenges we have to consider possibly university-industry-public-
governmental partnerships in Kazakhstan who w i l l be: 1) involved in promoting excellence 
in science and fostering research outcomes translation; 2) establishing industrial cooperation 
and partnerships; 3) properly analyzing and addressing important societal challenges; and 4) 
promoting research competitiveness and an appropriate business/innovation environment. 
These issues are of critical importance and a solution is urgently needed to be effectively 
solved in a t imely manner. In this century an evaluation methodology using informative 
indicators should be developed to assess research performance across four broad categories: 
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innovations and knowledge creation; intellectual and highly skilled potential development; 
research policy improvement and significant return on research investment; and industrial 
and public outcomes. 
The new methodology should be responsive to the requirements and needs of a l l parties 
involved in conducting and supporting research. This would be an ideal methodology in the 
field of evaluative bibliometrics, a subfield of quantitative science and technology studies. It 
might also be a powerful too l for evaluating institutional research advancements, proficiency 
in science, and a key driver for scientific excellence in biomedical research. 
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